SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond
Publication date: January 2021Source: The Lancet Diabetes & Endocrinology, Volume 9, Issue 1Author(s): Katherine R Tuttle
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
More News: Chronic Kidney Disease | Diabetes | Endocrinology | SGLT2 Inhibitors | Urology & Nephrology